Clinical Trials Logo

Clinical Trial Summary

The purpose of the Trident® II project is to introduce a cup system that modernizes and streamlines Stryker's acetabular shell portfolio. The Trident® II Clusterhole HA Shell combines the history of Stryker's Trident® shells with plasma spray CpTi with HA coating. Plasma spray coating and HA is considered to be the gold standard in orthopaedics today. This coating will help the cup to achieve early stability and long term fixation. One of the causes for implant failure is loosening and osteolysis. Osteolysis can be triggered when metal or polyethylene wear particles from the implant or bearing surfaces migrate between implant and surrounding host bone tissue. With the development of sequential irradiated and annealed highly crosslinked polyethylene (X3) wear rates (mean proximal, 2-dimensional and 3-dimensional) have been substantially reduced to 0.001 mm/y, calculated between 1 year and 5 years. The Trident® II Clusterhole HA shells have a plasma sprayed CpTi coating compared to the arc-deposition CpTi coating on legacy Trident® shells, both designed to allow bone ongrowth. With this study the investigators want to prove equivalent implant fixation of both type of cups. The primary objective is the assessment of prosthetic fixation and migration results after two years of the Trident® II Clusterhole HA shell compared to the legacy Trident® Hemi HA shell by means of RSA. It is hypothesized that they will perform equally. The secondary outcome measure will be long-term (10-year) survival based on the two-year migration patterns combined with clinical factors and radiographic aspects. In order to identify other clinical parameters besides the fixation of the prosthesis components, clinical scores and radiographic aspects will be correlated with the RSA outcome. The 10-year results will be used to verify the predicted long-term survival results.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03724058
Study type Interventional
Source Region Skane
Contact
Status Active, not recruiting
Phase N/A
Start date February 6, 2019
Completion date May 11, 2031

See also
  Status Clinical Trial Phase
Completed NCT00542516 - Comparison Between Two Techniques of Volemic Expansion in Hip Replacement Arthroplasty Phase 4
Active, not recruiting NCT03505580 - AMIStem-H Radiological Assessment
Completed NCT02162121 - Stimulating Catheter for Lumbar Plexus Block: Better Postoperative Analgesia? Phase 4
Recruiting NCT02346513 - Serum Level of Cobalt and Chromium After Ceramic on Metal Articulation Total Hip Arthroplasty N/A
Completed NCT01394744 - Determination of Metal Ion Serum Levels and Cytokines in Total Hip Replacement